Overview
Alphatec Holdings, Inc., based in the United States, operates primarily within the medical technology sector, focusing on the design and development of products for spinal surgery aimed at improving patient outcomes. The company's extensive portfolio includes innovative solutions that address key aspects of spine surgery such as bone preparation, spinal fixation, and vertebral stabilization. Key projects by Alphatec involve the advancement of its spine surgery technologies, which include novel interbody devices and biologics designed to optimize surgical procedures and enhance recovery. Through continuous innovation and strategic marketing, Alphatec Holdings strives to maintain and expand its presence in the competitive spine surgery market, continually evolving to meet the demands of healthcare providers and patients alike.
Basic Stats
The share price of Alphatec Holdings, Inc. as of September 4, 2025 is $16.55 / share. This is an increase of 3.24% from the prior week. The market cap (or net worth) of Alphatec Holdings, Inc. as of September 4, 2025 is $2,434.15 MM.
The Factor Analysis chart (below right) shows a view of Alphatec Holdings, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 2,434.15 MM |
| EV | 2,891.35 MM |
| Shares Out. | 147.03 MM |
| Earnings Date | |
| EPS (TTM) | -1.13 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.25 |
| Short Shares Avail. | 3.40 MM |
| Short Interest | 12.37 MM |
| Short Float | 10.66 % |
| Days to Cover | 7.22 days |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | 145.26 % |
| Volatility (1 yr) | 0.71 |
| Beta | 0.22 |
| Sharpe Ratio (1 yr) | 1.98 |
| Sortino Ratio (1 yr) | 4.92 |
| PE Ratio | -14.66 |
| Price/Book | 51.38 |
| Price/TBV | -16.55 |
| Book/Market | 0.02 |
| EBIT/EV | -0.06 |
| EBIT(3yr avg)/EV | -0.06 |
| ROA | -0.22 |
| ROE | -4.08 |
| ROIC | -0.25 |
| CROIC | 0.09 |
| OCROIC | 0.02 |
| Implied Volatility | 38.21 % |
| Put/Call OI Ratio | 0.22 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Alphatec Holdings, Inc. is $19.33. The forecasts range from a low of $14.14 to a high of $24.15. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Alphatec Holdings, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-06 | Morgan Stanley | Overweight | Maintains | |
| 2022-11-04 | Needham | Buy | Maintains | |
| 2022-10-12 | Jefferies | Buy | Initiate | |
| 2022-10-11 | Morgan Stanley | Overweight | Maintains | |
| 2022-09-12 | Morgan Stanley | Overweight | Initiate | |
| 2022-08-08 | Goldman Sachs | Neutral | Maintains | |
| 2022-05-26 | Needham | Buy | Maintains | |
| 2022-05-06 | HC Wainwright & Co. | Buy | Maintains | |
| 2022-03-02 | Piper Sandler | Overweight | Maintains | |
| 2021-12-03 | Goldman Sachs | Neutral | Initiate | |
| 2021-11-05 | Needham | Buy | Maintains | |
| 2021-08-25 | Needham | Buy | Initiate | |
| 2021-08-04 | Canaccord Genuity | Buy | Maintains | |
| 2021-03-05 | HC Wainwright & Co. | Buy | Maintains | |
| 2020-10-20 | Stifel | Buy | Initiate | |
| 2020-10-12 | HC Wainwright & Co. | Buy | Maintains | |
| 2020-10-08 | Canaccord Genuity | Buy | Maintains | |
| 2020-09-03 | Cowen & Co. | Outperform | Initiate | |
| 2020-06-18 | Northland Capital Markets | Outperform | Initiate | |
| 2020-04-09 | H.C. Wainwright | Buy | Reiterate | |
| 2020-03-06 | H.C. Wainwright | Buy | Reiterate | |
| 2019-08-28 | Canaccord Genuity | Buy | Initiate | |
| 2019-08-06 | H.C. Wainwright | Buy | Maintains | |
| 2019-08-05 | Piper Jaffray | Overweight | Initiate | |
| 2017-10-16 | Lake Street | Buy | Initiate | |
| 2017-08-14 | H.C. Wainwright | Buy | Initiate | |
| 2016-03-14 | Northland Securities | Outperform | Underperform | Downgrade |
| 2015-08-05 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2015-05-01 | Canaccord Genuity | Buy | Maintains | |
| 2014-03-18 | Jefferies | Buy | Maintains | |
| 2013-03-01 | Jefferies | Buy | Maintains | |
| 2012-08-08 | Canaccord Genuity | Buy | Maintains | |
| 2023-01-12 | Lake Street | Buy | Maintains | |
| 2023-03-01 | Morgan Stanley | Overweight | Maintains | |
| 2023-03-01 | HC Wainwright & Co. | Buy | Reiterate | |
| 2023-03-01 | Needham | Buy | Reiterate | |
| 2023-04-20 | Needham | Buy | Reiterate | |
| 2023-04-17 | Needham | Buy | Maintains | |
| 2023-05-05 | HC Wainwright & Co. | Buy | Reiterate | |
| 2023-05-05 | Needham | Buy | Maintains | |
| 2023-05-26 | Needham | Buy | Buy | Reiterate |
| 2023-05-08 | Morgan Stanley | Overweight | Maintains | |
| 2023-06-26 | Lake Street | Buy | Buy | Maintains |
| 2023-08-04 | Stifel | Buy | Buy | Maintains |
| 2023-08-04 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-08-04 | Canaccord Genuity | Buy | Buy | Maintains |
| 2023-08-04 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2023-08-04 | Needham | Buy | Buy | Maintains |
| 2024-05-08 | Needham | Buy | Buy | Reiterate |
| 2023-11-07 | Stifel | Buy | Buy | Maintains |
| 2023-11-07 | Needham | Buy | Buy | Maintains |
| 2023-10-20 | Roth MKM | Buy | Initiate | |
| 2023-11-14 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-12-19 | Needham | Buy | Buy | Maintains |
| 2024-03-20 | Canaccord Genuity | Buy | Buy | Reiterate |
| 2024-03-20 | Needham | Buy | Buy | Maintains |
| 2024-03-04 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-02-28 | Needham | Buy | Buy | Reiterate |
| 2024-03-28 | Needham | Buy | Buy | Maintains |
| 2024-05-08 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-03-13 | Needham | Buy | Buy | Reiterate |
| 2024-07-11 | Stifel | Buy | Buy | Maintains |
| 2024-07-15 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-08-30 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-08-01 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-08-01 | Stifel | Buy | Buy | Maintains |
| 2024-08-01 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-08-01 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-08-01 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-09-03 | Lake Street | Buy | Buy | Maintains |
| 2024-07-25 | Canaccord Genuity | Buy | Buy | Maintains |
| 2025-02-27 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-02-27 | Needham | Buy | Buy | Reiterate |
| 2024-08-22 | Needham | Buy | Buy | Maintains |
| 2024-08-01 | Needham | Buy | Buy | Reiterate |
| 2024-10-31 | Needham | Buy | Buy | Reiterate |
| 2024-10-31 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-11-19 | Barclays | Overweight | Overweight | Maintains |
| 2025-01-14 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2025-01-22 | Barclays | Overweight | Overweight | Maintains |
| 2025-01-13 | Needham | Buy | Buy | Maintains |
| 2025-05-02 | Needham | Buy | Buy | Reiterate |
| 2025-04-14 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2025-05-02 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2025-08-04 | Barclays | Overweight | Overweight | Maintains |
